Finance News – Domestic Manufacturing
What is your interest today?
Bitcoin
Crypto
Btc
Tariffs
Ceo
Cryptocurrency
Crypto Assets
Stocks
Investors
Stock
Stock Market
Shares
Ethereum
Markets
Price
Xrp
Investment
Blockchain
Sec
Eth
Stablecoin
Etf
Trade
Earnings
Revenue
Solana
Index
Bse
China
Coinbase
Token
Ipo
Nasdaq
Wall Street
Usd
Trade War
Inflation
Interest Rates
Economy
Profit
Digital Assets
Sensex
Sp 500
Nvidia
Gold
Nse
Binance
Federal Reserve
Treasury
Bse Sensex
Tariff War
Elections
Yuan
Subsidiaries
Susde
Boards
Ls Industries
Core Team
Founder Led Ventures
Abl
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
CNBC Business • May 21, 2025
CSX CEO says industrial projects are growing amid push for domestic manufacturing
CSX’s leadership highlighted that increased government initiatives to boost local manufacturing are driving higher demand for freight transportation, potentially enhancing the comp...
Read Full Article →
CNBC Business • May 05, 2025
Trump signs order to boost domestic drug manufacturing as pharma tariffs loom
The directive aims to enhance domestic production of medications, potentially reducing reliance on imports and impacting the cost structure of pharmaceuticals in the U.S. market.
Read Full Article →